(Alliance News) - AstraZeneca PLC and Bristol-Myers Squibb Co are considering merging in a deal worth USD400 billion, the Financial Times reported on Sunday. Read More
(Alliance News) - Stocks in London are set to open higher on Monday as hopes for renewed US-Iran diplomacy offset caution following a joint US-Japan intervention to strengthen the yen. Read More
(Alliance News) - AstraZeneca PLC on Friday said the European Commission has approved Datroway for the first-line treatment of some patients with an aggressive form of breast cancer. Read More
(Alliance News) - The FTSE 100 closed higher in London on Monday as investors welcomed a temporary pause in hostilities between the US and Iran, which helped drive the oil price sharply lower. Read More
(Alliance News) - European shares moved higher at the start of the week, as a pause in US and Iran hostilities lifted hopes of a prolonged peace agreement, and sent oil into reverse. Read More
(Alliance News) - AstraZeneca PLC on Monday reported stronger-than-expected earnings in its second quarter, with sales broadly as forecast, together with mixed news for its drugs pipeline. Read More
(Alliance News) - AstraZeneca affirmed annual guidance, while Vodafone lifted its outlook after the Safaricom deal. Elsewhere, DCC Energy has agreed to a takeover, Serica Energy will buy Pharos Energy but IP Group's suitor will not make an offer for the firm. Read More
(Alliance News) - AstraZeneca PLC on Thursday said a combination with its Etcamah drug has been approved for treatment of breast cancer in the EU. Read More
(Alliance News) - AstraZeneca PLC on Tuesday said it has entered into a deal to license a lung cancer therapy, in a deal worth up to USD1.5 billion. Read More
(Alliance News) - BP flags lower second-quarter production but expects stronger oil price realisations, while AstraZeneca agrees a lung cancer licensing deal with Dizal Pharmaceutical worth up to USD1.5 billion. Read More
(Alliance News) - GSK reports positive Jemperli trial data, while Plus500 posts record first-half revenue. Elsewhere, Heathrow's first-half passenger traffic edged higher despite a June decline caused by weaker Middle East travel. Read More